Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy.

M Bloemendal, M J A Rietveld, W W van Willigen,W R Gerritsen,C G Figdor,J J Bonenkamp,H Westdorp,S Boudewijns,R H T Koornstra,E M M Adang,G Schreibelt,P B Ottevanger,I J M de Vries,K F Bol

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico（2019）

引用 7|浏览41

暂无评分

摘要

This is the first description of HRQoL in melanoma patients receiving dendritic cell vaccination. We show the expected improvement in global health status after surgical treatment of stage III melanoma. Thus, adjuvant dendritic cell vaccination does not seem to hamper this improvement, as shown in our small explorative study.

查看译文

关键词

Adjuvant therapy,Cancer,Dendritic cell vaccination,Immunotherapy,Melanoma,Stage III melanoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要